PHOENIX showcased its services at the Partnership Opportunities in Drug Delivery (PODD) event, held on October 28-29, 2024, at the Westin Copley Place in Boston.
This annual event, known as Partnership Opportunities in Drug Delivery (PODD)®, focuses on the latest advancements in drug delivery science while serving as a hub for networking and forging new collaborations. PODD highlights a diverse array of cutting-edge drug delivery technologies designed to enhance the administration of various treatments, including proteins, peptides, mRNA therapies, oncology drugs, and small molecules.
PHOENIX participated at MyBiotech’s booth (#12), proudly represented by Scientific Coordinator and PHOENIX SEP CEO Dr. Nazende Günday-Türeli. Nanomol Technologies also had a booth and presented PHOENIX to visitors.